Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.4%

5 terminated/withdrawn out of 211 trials

Success Rate

95.5%

+9.0% vs industry average

Late-Stage Pipeline

23%

49 trials in Phase 3/4

Results Transparency

10%

11 of 107 completed trials have results

Key Signals

31 recruiting11 with results

Enrollment Performance

Analytics

N/A

56(36.4%)

Phase 2

34(22.1%)

Phase 4

30(19.5%)

Phase 3

19(12.3%)

Phase 1

15(9.7%)

154Total

N/A(56)

Phase 2(34)

Phase 4(30)

Phase 3(19)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (211)

Showing 20 of 211 trials

NCT03331718Phase 3Completed

PoLyglycolic Acid Felt reiNforcEmenT of the PancreaticoJejunostomy (PLANET-PJ Trial)

Role: collaborator

NCT07550686Not ApplicableRecruiting

Comparison of Patient Understanding and Anxiety According to the Delivery Method of Educational Videos

Role: collaborator

NCT06350617Not ApplicableRecruiting

Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients

Role: collaborator

NCT06270238Not ApplicableRecruiting

Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients

Role: collaborator

NCT05340361Active Not Recruiting

Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT

Role: collaborator

NCT06330038Phase 4Recruiting

Anesthesia and Non-small Cell Lung Cancer Recurrence

Role: collaborator

NCT06893783Phase 2Recruiting

Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients

Role: collaborator

NCT07525089Not ApplicableEnrolling By Invitation

Human Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE)

Role: collaborator

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT06687941Phase 1Recruiting

A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Role: collaborator

NCT07491029Not ApplicableNot Yet Recruiting

AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke

Role: collaborator

NCT07359105Not ApplicableRecruiting

Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)